Aytu BioPharma News

Aytu BioPharma | 8-K: Aytu BioPharma Reports Fiscal 2024 Third Quarter Operational and Financial Results

May 15 16:22 ET

Aytu BioPharma | DEFA14A: Others

May 10 16:11 ET

Aytu BioPharma | DEF 14A: Definitive information statements

May 10 16:09 ET

Aytu BioPharma | 8-K: Current report

Feb 14 16:21 ET

Aytu BioPharma | 8-K: Current report

Nov 17, 2023 16:10 ET

Aytu BioPharma | 8-K: Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

Nov 14, 2023 16:10 ET

Aytu BioPharma | 8-K: Current report

Oct 26, 2023 08:05 ET

Aytu BioPharma | 8-K: Current report

Oct 6, 2023 16:30 ET

Aytu BioPharma | NT 10-K: Others

Sep 29, 2023 16:15 ET

Aytu BioPharma | 8-K: Current report

Sep 27, 2023 16:20 ET

Aytu BioPharma | 8-K: Current report

Aug 15, 2023 16:10 ET

Aytu BioPharma | 8-K: Current report

Jul 31, 2023 08:05 ET

Aytu BioPharma | 8-K: Current report

Jul 10, 2023 08:05 ET

Aytu BioPharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jun 23, 2023 16:54 ET

Aytu BioPharma | 8-K: Current report

Jun 12, 2023 17:19 ET

Aytu BioPharma | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jun 5, 2023 17:24 ET

Aytu BioPharma | 8-K: Current report

May 22, 2023 08:00 ET

Aytu BioPharma | 8-K: Aytu BioPharma Reports Third Quarter of Fiscal Year 2023 Financial Results

May 11, 2023 16:10 ET

Aytu BioPharma | S-1: General form for registration of securities under the Securities Act of 1933

May 1, 2023 17:20 ET

Aytu BioPharma | 8-K: Current report

May 1, 2023 08:05 ET